Showmenu

Muna Anwar Alnimri, M.B.B.S. for UC Davis Health

Muna Anwar Alnimri, M.B.B.S.

Muna Anwar Alnimri, M.B.B.S.

Professor, Department of Medicine

To see if Muna Anwar Alnimri is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Specialties

Nephrology

Surgery - Transplant

Transplant Nephrology

Department

Internal Medicine

Locations and Contact

48X Complex


4868 X Street, Suite 3A
Sacramento, CA 95817

Get Directions

Clinic Phone: 916-734-2111

Clinic Fax: 916-734-2300

Philosophy of Care

Dr. Alnimri believes that patients can contribute to their own health care and help make decisions easier by interacting with their physicians. Direct communications with health care provider builds trust much needed for ultimate excellent outcomes.

Clinical Interests

Dr. Alnimri is a Transplant Nephrologist offering care to adults with kidney and Pancreas transplant. She evaluates patients for kidney and pancreas transplant and those interested in living kidney donation. 

Research/Academic Interests

Dr. Alnimri is interested in clinical trials including immunosuppression medicines in the pipeline, desensitization protocols, follow up of living kidney donors, and diagnosis of rejection without kidney biopsy.

Division

Transplant Nephrology

Center/Program Affiliation

UC Davis Medical Group

Medical School

M.B.B.S., Jordan University School of Medicine, Amman, Jordan 1987

Internship

Internal Medicine, Unity Health System, Rochester NY 2006-2008

Residency

Internal Medicine, Unity Health System, Rochester NY 2006-2008

Fellowship

Nephrology, Oregon Health Sciences University, Portland OR 1997-1999

Fellowship

Transplant Nephrology, UC San Francisco, San Francisco CA 2008-2009

Diamond Doctor Award, UC Davis, 2024,

Fellow of the Royal College of Physicians UK, 2005,

Honorary Registrar University College, London, 2001,

Bromberg JS, et al. Elevation of donor derived Cell free DNA before Biopsy proven rejection in Kidney transplant. Transplantation. 2024.

Jespersen Nizamic T, Huang Y, Alnimri M, Cheng M, Chen LX, Jen KY. COVID-19 Manifesting as Renal Allograft Dysfunction, Acute Pancreatitis, and Thrombotic Microangiopathy: A Case Report. Transplant Proc. 2021 May;53(4):1211-1214. doi:10.1016/j.transproceed.2020.10.048. Epub 2020 Dec 18. PMID:33436168.

Howard JH 3rd, Darrow M, Chen LX, Alnimri M, Jen KY. Tonsillar Kaposi sarcoma in a renal transplant patient. Transpl Infect Dis. 2020 Oct;22(5):e13347. doi:10.1111/tid.13347. Epub 2020 Jun 16. PMID:32495980.

Freidman G, Moss O, Alnimri M, Chen L. Determination of type 2 DM risk in potential living kidney donors : A single center protocol and experience. Transplantation. 2020 Sep;104(S3):S87-S88.

Chen LX, De Mattos A, Bang H, Vu CT, Gandhi M, Alnimri M, Gallay B, Fananapazir G. Angioplasty vs stent in the treatment of transplant renal artery stenosis. Clin Transplant. 2018 Apr;32(4):e13217. doi:10.1111/ctr.13217. Epub 2018 Feb 28. PMID:29394514.

Patel S, Pankewycz O, Kohli R, Said M, Alnimri M, Feng L, Laftavi MR. Obesity in renal transplantation: the role of induction therapy on long-term outcomes. Transplant Proc. 2011 Mar;43(2):469-71. doi:10.1016/j.transproceed.2011.01.040. PMID:21440736.

Laftavi M, Hai F, Laftavi H, Feng L, Said M, Patel S, Koli R, Alnimri M, Pankewycz O. Mycophenolic acid dose reductions result in poor long term renal allograft survival: comparison between mycophenolate sodium, and mycophenolate mofetil. Transplantation Proceedings. March 2011; Vol 43, issue 2  pages 478-481.

Alnimri M, Laftavi MR, Kohli R, Said M, Feng L, Patel S, Pankewycz O. African-American women and older patients are at risk for a greater decline in renal function following living kidney donation. Transplant Proc. 2011 Mar;43(2):512-5. doi:10.1016/j.transproceed.2011.01.041. PMID:21440747.

Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Transplant Proc. 2011 Mar;43(2):458-61. doi:10.1016/j.transproceed.2011.01.035. PMID:21440733.

Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy. Transplant Proc. 2011 Mar;43(2):466-8. doi:10.1016/j.transproceed.2011.01.039. PMID:21440735.